Javier San Martin - 01 Oct 2024 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATHA	Restricted Stock Units	Award	$0	+140,000		$0.000000	140,000	01 Oct 2024	Common Stock	140,000		Direct	F1, F2
transaction	ATHA	Stock Option (Right to Buy)	Award	$0	+140,000		$0.000000	140,000	01 Oct 2024	Common Stock	140,000	$0.4499	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
F2	One-third (1/3rd) of the RSUs shall vest on each of December 31, 2024, June 30, 2025 and December 31, 2025, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the applicable vesting dates.
F3	One-third (1/3rd) of the shares subject to the option shall vest on each of December 31, 2024, June 30, 2025 and December 31, 2025, subject to the Reporting Person continuing to be a Service Provider through the applicable vesting dates.